Suppr超能文献

苄普地尔、地尔硫䓬和维拉帕米对清醒犬心房不应期和心率的影响:与奎尼丁的比较。

Effects of bepridil, diltiazem and verapamil on atrial refractoriness and heart rate in the conscious dog: comparison with quinidine.

作者信息

Boucher M, Dubray C, Duchêne-Marullaz P

机构信息

INSERM U.195, Faculty of Medicine, Clermont-Ferrand, France.

出版信息

Gen Pharmacol. 1991;22(4):581-7. doi: 10.1016/0306-3623(91)90060-j.

Abstract
  1. Bepridil at cumulative doses between 1.25 and 8.75 mg/kg and quinidine between 2.5 and 17.5 mg/kg given in conscious dogs with chronic atrioventricular block and implanted atrial pacing electrodes, dose-relatedly lengthened atrial effective refractory period (AERP), as reflected by the decrease in maximal atrial frequency determined by pacing. 2. Diltiazem shortened AERP at 0.25 mg/kg and lengthened it at 1.75 mg/kg, but both effects were very slight. 3. Verapamil between 0.06 and 0.435 mg/kg did not alter AERP at all. 4. Except for diltiazem at 0.75 and 1.75 mg/kg and bepridil at 8.75 mg/kg, each dose of each drug increased atrial rate. Each drug produced an increase in ventricular rate and a short-lasting lowering in mean blood pressure. 5. Thus, these results indicate that bepridil exhibits more marked antiarrhythmic potentialities than quinidine and that the atrial and ventricular tachycardic effects observed are mainly baroreceptor reflex effects.
摘要
  1. 在清醒的患有慢性房室传导阻滞并植入心房起搏电极的犬中,给予累积剂量在1.25至8.75毫克/千克之间的苄普地尔以及2.5至17.5毫克/千克之间的奎尼丁,剂量依赖性地延长了心房有效不应期(AERP),这通过起搏测定的最大心房频率降低得以体现。2. 地尔硫䓬在0.25毫克/千克时缩短了AERP,在1.75毫克/千克时延长了AERP,但两种效应都非常轻微。3. 0.06至0.435毫克/千克之间的维拉帕米根本没有改变AERP。4. 除了0.75和1.75毫克/千克的地尔硫䓬以及8.75毫克/千克的苄普地尔外,每种药物的每个剂量都增加了心房率。每种药物都使心室率增加,并使平均血压短暂降低。5. 因此,这些结果表明苄普地尔比奎尼丁表现出更显著的抗心律失常潜力,并且观察到的心房和心室心动过速效应主要是压力感受器反射效应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验